---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-383726"
form_type: "8-K"
ticker: "RNTX"
cik: "0001420565"
company_name: "Rein Therapeutics, Inc."
filed_at: "2026-09-04T20:31:51+00:00"
generated_at: "2026-09-04T20:33:15.698843+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "low"
source: SEC EDGAR
---

# Rein Therapeutics posts LTI-03 presentation; no specifics in filing

## Summary
- On September 4, 2026, Rein Therapeutics published a presentation on LTI-03 on its IR website.
- The presentation is attached as Exhibit 99.1; the provided text does not include its content.
- No financial, clinical, or regulatory updates are disclosed in the 8-K body.

## SEC filing metadata
- accession: 0001193125-26-383726
- form_type: 8-K
- ticker: RNTX
- cik: 0001420565
- company_name: Rein Therapeutics, Inc.
- filed_at: 2026-09-04T20:31:51+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1420565/000119312526383726/0001193125-26-383726-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1420565/000119312526383726/d111215d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-383726
- JSON: https://secwatch.observer/filing/0001193125-26-383726.json
- Plain text: https://secwatch.observer/filing/0001193125-26-383726.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.